substance p has been researched along with Arteriosclerosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkels, R; Grosser, N; Gründemann, D; Schömig, E; Schröder, H; Taubert, D | 1 |
| Braun, M; Hohlfeld, T; Kienbaum, P; Sarbia, M; Schrör, K; Weber, AA | 1 |
| Doi, H; Kugiyama, K; Matsumura, T; Ohta, Y; Sugiyama, S; Yasue, H | 1 |
| Andrews, NP; Husain, S; Mulcahy, D; Panza, JA; Quyyumi, AA | 1 |
| Cooper, A; Heagerty, AM | 1 |
| Quyyumi, AA | 1 |
| Boon, NA; Fox, KA; Labinjoh, C; Ludlam, CA; Newby, DE; Webb, DJ; Wright, RA | 1 |
| Amann, K; Bleeke, T; Kübler, W; Tiefenbacher, CP; Vahl, C; Vogt, A | 1 |
| Ayajiki, K; Okamura, T; Ozaki, M; Shiomi, M; Toda, N | 1 |
| Arnal, JF; Bayard, F; Castano, C; Darblade, B; Gourdy, P; Maupas, E; Michel, JB; Mugniot, A | 1 |
| Black, PH; Garbutt, LD | 1 |
| Bult, H; De Meyer, GR; Herman, AG | 1 |
| Chester, AH; Moncada, S; O'Neil, GS; Tadjkarimi, S; Yacoub, MH | 1 |
| Herman, AG; Jordaens, FH; Van Hove, CE; Van Hoydonck, AE; Verbeuren, TJ | 1 |
| Bossaller, C; Habib, GB; Henry, PD; Wells, S; Williams, C; Yamamoto, H | 1 |
| Berkenboom, G; Depierreux, M; Fontaine, J | 1 |
2 review(s) available for substance p and Arteriosclerosis
| Article | Year |
|---|---|
Effects of aspirin on endothelial dysfunction in atherosclerosis.
Topics: Acetylcholine; Animals; Arteriosclerosis; Aspirin; Drug Interactions; Endothelium, Vascular; Humans; Nitroprusside; Platelet Aggregation Inhibitors; Substance P; Vascular Resistance; Vasodilator Agents | 1998 |
Stress, inflammation and cardiovascular disease.
Topics: Acute-Phase Proteins; Adrenal Cortex Hormones; Arteriosclerosis; Brain; Cardiovascular Diseases; Catecholamines; Cytokines; Fibrinolysis; Glucagon; Homocysteine; Human Growth Hormone; Humans; Inflammation; Intercellular Adhesion Molecule-1; Neurons; Renin; Risk Factors; Stress, Psychological; Substance P; Vascular Cell Adhesion Molecule-1 | 2002 |
1 trial(s) available for substance p and Arteriosclerosis
| Article | Year |
|---|---|
Aspirin improves endothelial dysfunction in atherosclerosis.
Topics: Acetylcholine; Arteriosclerosis; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Reproducibility of Results; Substance P; Vasodilation; Vasodilator Agents | 1998 |
13 other study(ies) available for substance p and Arteriosclerosis
| Article | Year |
|---|---|
Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cells, Cultured; Chelating Agents; Citrulline; Coronary Vessels; Egtazic Acid; Endothelium, Vascular; Free Radical Scavengers; Homeostasis; Humans; In Vitro Techniques; Nitric Oxide; Oxidants; Substance P; Superoxides; Swine | 2004 |
Antiatherosclerotic effects of oral naftidrofuryl in cholesterol-fed rabbits involve inhibition of neutrophil function.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Luminescent Measurements; Luminol; Male; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nafronyl; Neutrophils; Nitric Oxide; Rabbits; Random Allocation; Substance P; Vasodilator Agents; Zymosan | 1995 |
Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11).
Topics: Administration, Oral; Animals; Aorta, Thoracic; Arteriosclerosis; Atrial Natriuretic Factor; Body Weight; Cholesterol, Dietary; Diet, Atherogenic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycopeptides; Hemodynamics; Hypercholesterolemia; Indans; Lipids; Male; Natriuretic Peptide, C-Type; Neprilysin; Nitroprusside; Organ Culture Techniques; Propionates; Proteins; Rabbits; Substance P; Vasodilation | 1996 |
Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Arteries; Arteriosclerosis; Bradykinin; Cardiomyopathies; Coronary Circulation; Endothelium, Vascular; Female; Heart; Heart Failure; Heart Transplantation; Humans; Hypercholesterolemia; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Nitroprusside; Substance P; Vasodilation | 1998 |
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Topics: Adult; Arteries; Arteriosclerosis; Blood Flow Velocity; Case-Control Studies; Endothelium, Vascular; Female; Fibrinolysis; Forearm; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Plethysmography; Risk Factors; Smoking; Substance P; Thrombosis; Tissue Plasminogen Activator | 1999 |
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis.
Topics: Acetylcholine; Animals; Arteriosclerosis; Atrial Appendage; Biopterins; Cholesterol; Coronary Vessels; Diet, Atherogenic; Dose-Response Relationship, Drug; Endothelium, Vascular; Histamine; Humans; In Vitro Techniques; Nitroprusside; Pteridines; Pterins; Serotonin; Substance P; Swine, Miniature; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |
Comparison of endothelium-dependent relaxation in carotid arteries from Japanese white and Watanabe heritable hyperlipidemic rabbits.
Topics: Acetylcholine; Animals; Arteriosclerosis; Carotid Arteries; Cholesterol; Hyperlipidemias; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits; Species Specificity; Substance P; Vasodilator Agents | 2000 |
Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Arteriosclerosis; Atrial Natriuretic Factor; Body Weight; Bradykinin; Cholesterol; Cholesterol, HDL; Drug Evaluation, Preclinical; Indans; Male; Mice; Mice, Knockout; Neprilysin; Propionates; Protease Inhibitors; Pyridines; Substance P; Thiazepines; Triglycerides | 2001 |
Selective muscarinic alterations of nitric oxide-mediated relaxations by neointima.
Topics: Adenosine Triphosphate; Animals; Arteriosclerosis; Calcimycin; Dose-Response Relationship, Drug; Male; Nitric Oxide; Rabbits; Receptors, Muscarinic; Substance P; Vasodilation | 1992 |
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arginine; Arteriosclerosis; Bradykinin; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Humans; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Substance P; Vasoconstriction; Vasodilation | 1990 |
Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta.
Topics: Acetylcholine; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Calcimycin; Cholesterol, Dietary; Male; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Nitroglycerin; Rabbits; Substance P | 1990 |
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.
Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Calcimycin; Coronary Vessels; Cyclic GMP; Endothelium; Histamine; Humans; Nitric Oxide; Nitroglycerin; Rabbits; Receptors, Muscarinic; Substance P; Vasodilation; Vasodilator Agents | 1987 |
The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline.
Topics: Adolescent; Adult; Arteriosclerosis; Child; Child, Preschool; Coronary Vessels; Endothelium, Vascular; Female; Heart Failure; Humans; In Vitro Techniques; Infant; Isoproterenol; Male; Middle Aged; Norepinephrine; Potassium Chloride; Receptors, Adrenergic, beta; Substance P; Vasodilation | 1987 |